Published in J Clin Endocrinol Metab on February 01, 2001
The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc (2008) 6.33
Effects of poor and short sleep on glucose metabolism and obesity risk. Nat Rev Endocrinol (2009) 4.09
Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2013) 2.43
Epidemiology of Obstructive Sleep Apnea: a Population-based Perspective. Expert Rev Respir Med (2008) 1.94
Pathophysiology of adult obstructive sleep apnea. Proc Am Thorac Soc (2008) 1.52
Screening for sleep-disordered breathing and excessive daytime sleepiness in adolescent girls with polycystic ovarian syndrome. J Pediatr (2011) 1.46
Lack of regular exercise, depression, and degree of apnea are predictors of excessive daytime sleepiness in patients with sleep apnea: sex differences. J Clin Sleep Med (2008) 1.24
The Pregnancy in Polycystic Ovary Syndrome II (PPCOS II) trial: rationale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of infertility in women with polycystic ovary syndrome. Contemp Clin Trials (2012) 1.15
Daytime sleepiness in obesity: mechanisms beyond obstructive sleep apnea--a review. Sleep (2012) 1.08
Novel retrospective, respiratory-gating method enables 3D, high resolution, dynamic imaging of the upper airway during tidal breathing. Magn Reson Med (2013) 1.07
Cardiometabolic aspects of the polycystic ovary syndrome. Endocr Rev (2012) 1.05
Treatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome. J Clin Endocrinol Metab (2010) 1.03
Impact of obstructive sleep apnea on insulin resistance and glucose tolerance in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2008) 0.97
Cardiometabolic aspects of polycystic ovarian syndrome. Vasc Health Risk Manag (2007) 0.93
Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions. Fertil Steril (2010) 0.92
Polycystic Ovary Syndrome and Obstructive Sleep Apnea. Sleep Med Clin (2008) 0.90
Diabetes is an independent risk factor for severe nocturnal hypoxemia in obese patients. A case-control study. PLoS One (2009) 0.89
Sleep and diabetes. Int J Endocrinol (2010) 0.89
What do we know about metabolic syndrome in adolescents with PCOS? J Turk Ger Gynecol Assoc (2014) 0.88
Long term health consequences of polycystic ovarian syndrome: a review analysis. Hippokratia (2009) 0.87
Impact of Adenotonsillectomy on Insulin Resistance and Lipoprotein Profile in Nonobese and Obese Children. Chest (2016) 0.85
Sleep and cardiometabolic function in obese adolescent girls with polycystic ovary syndrome. Sleep Med (2012) 0.85
CrossTalk proposal: Metabolic syndrome causes sleep apnoea. J Physiol (2016) 0.84
The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev (2016) 0.83
Metabolic dysfunction in pcos: Relationship to obstructive sleep apnea. Steroids (2011) 0.81
Sleep Apnea Symptoms in Diabetics and their First Degree Relatives. Int J Prev Med (2012) 0.80
Sleep Apnea and its association with the Stress System, Inflammation, Insulin Resistance and Visceral Obesity. Sleep Med Clin (2007) 0.80
Gonadal steroid modulation of sleep and wakefulness in male and female rats is sexually differentiated and neonatally organized by steroid exposure. Endocrinology (2013) 0.78
Metabolic, behavioral, and reproductive effects of vertical sleeve gastrectomy in an obese rat model of polycystic ovary syndrome. Obes Surg (2014) 0.78
Obstructive sleep apnea and metabolic dysfunction in polycystic ovary syndrome. Best Pract Res Clin Endocrinol Metab (2010) 0.78
Does enhanced insulin sensitivity improve sleep measures in patients with obstructive sleep apnea: a randomized, placebo-controlled pilot study. Sleep Med (2016) 0.78
Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women. Fertil Steril (2012) 0.77
Adverse Pregnancy Conditions, Infertility, and Future Cardiovascular Risk: Implications for Mother and Child. Cardiovasc Drugs Ther (2015) 0.77
Excessive daytime sleepiness and body composition: a population-based study of adults. PLoS One (2014) 0.77
The metabolic effects of drugs used for the treatment of polycystic ovary syndrome. J Turk Ger Gynecol Assoc (2013) 0.77
Excessive daytime sleepiness in sleep apnea: it is not just apnea hypopnea index. Sleep Med (2008) 0.77
World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease: part 4. Diabetes Care (2011) 0.75
Diagnosis and treatment of polycystic ovary syndrome (PCOS): an interview with Richard Legro. BMC Med (2015) 0.75
Sleep, sleep disturbance, and fertility in women. Sleep Med Rev (2014) 0.75
A Gender-Specific Association between Self-Reported Snoring and Hemoglobin A1c Levels in a General Population without Type 2 Diabetes Mellitus. Yonsei Med J (2017) 0.75
Polycystic ovary syndrome and the risk of obstructive sleep apnea: a meta-analysis and review of the literature. Endocr Connect (2017) 0.75
Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med (2001) 5.94
The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev (2000) 5.40
Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med (1998) 4.65
Next-day memory impairment with triazolam use. Lancet (1991) 4.65
Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab (2004) 4.48
Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab (1997) 4.47
Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab (2000) 4.34
Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry (2002) 3.82
Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab (2003) 3.33
The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med (1998) 3.16
Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. J Clin Endocrinol Metab (2001) 2.97
Association of hypertension and sleep-disordered breathing. Arch Intern Med (2000) 2.95
Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. N Engl J Med (1991) 2.93
Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nat Med (1997) 2.73
Hypothalamic-pituitary-adrenal axis dysregulation in sexually abused girls. J Clin Endocrinol Metab (1994) 2.71
Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. J Clin Endocrinol Metab (2001) 2.66
Prevalence of sleep disorders in the Los Angeles metropolitan area. Am J Psychiatry (1979) 2.60
Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (1) N Engl J Med (1988) 2.58
Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depression. J Clin Endocrinol Metab (2005) 2.46
Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci U S A (1989) 2.43
Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab (1999) 2.40
Circulating leptin levels during acute experimental endotoxemia and antiinflammatory therapy in humans. J Infect Dis (1998) 2.27
Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab (1991) 2.23
Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion. J Clin Endocrinol Metab (1994) 2.22
Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest (1995) 2.20
Central serous chorioretinopathy in endogenous hypercortisolism. Arch Ophthalmol (1993) 2.20
Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci U S A (2000) 2.19
Evaluation, diagnosis, and treatment of clinical conditions related to sleep. JAMA (1970) 2.16
Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. J Clin Endocrinol Metab (2004) 2.11
Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev (1996) 2.11
Chronic insomnia and activity of the stress system: a preliminary study. J Psychosom Res (1998) 2.06
Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med (1993) 2.05
"Leaner and less fit" children have a better cardiometabolic profile than their "heavier and more fit" peers: the Healthy Growth Study. Nutr Metab Cardiovasc Dis (2013) 2.04
Sleep apnea and sleep disruption in obese patients. Arch Intern Med (1994) 1.98
Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum (1994) 1.97
Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2) N Engl J Med (1988) 1.95
Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest (1996) 1.94
Adverse events after triazolam substitution. Lancet (1993) 1.90
Sleep apnoea in a hypertensive population. Lancet (1984) 1.90
Short sleep duration and obesity: the role of emotional stress and sleep disturbances. Int J Obes (Lond) (2008) 1.86
Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2. J Clin Endocrinol Metab (2005) 1.84
Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol Endocrinol (1999) 1.84
Plasma leptin levels are increased in survivors of acute sepsis: associated loss of diurnal rhythm, in cortisol and leptin secretion. J Clin Endocrinol Metab (1998) 1.80
Obesity without sleep apnea is associated with daytime sleepiness. Arch Intern Med (1998) 1.79
Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease. Ann Intern Med (1999) 1.79
Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. J Clin Endocrinol Metab (1997) 1.79
Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance. J Intern Med (2003) 1.78
Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy. N Engl J Med (1994) 1.78
Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications. Ann Intern Med (1998) 1.74
Chronic insomnia is associated with a shift of interleukin-6 and tumor necrosis factor secretion from nighttime to daytime. Metabolism (2002) 1.71
Insomnia in central Pennsylvania. J Psychosom Res (2002) 1.71
Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science (1991) 1.70
Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc Natl Acad Sci U S A (2000) 1.69
Lack of utility of (111)In-pentetreotide scintigraphy in localizing ectopic ACTH producing tumors: follow-up of 18 patients. J Clin Endocrinol Metab (1999) 1.68
Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc Natl Acad Sci U S A (1999) 1.68
Mechanisms of stress: a dynamic overview of hormonal and behavioral homeostasis. Neurosci Biobehav Rev (1992) 1.66
Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab (1993) 1.65
IL-6 and its circadian secretion in humans. Neuroimmunomodulation (2005) 1.64
Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor beta. J Exp Med (1997) 1.61
Melatonin secretion after surgery. Lancet (2000) 1.61
A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc Natl Acad Sci U S A (1989) 1.61
Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J Immunol (1998) 1.59
Effects of lovastatin and pravastatin on sleep efficiency and sleep stages. Clin Pharmacol Ther (1991) 1.59
Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepines. JAMA (1979) 1.59
In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. Endocrinology (1996) 1.57
Thyroid hormone concentrations in depressed and nondepressed adolescents: group differences and behavioral relations. J Am Acad Child Adolesc Psychiatry (1996) 1.57
Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation (1998) 1.57
Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis. Cancer Res (1990) 1.57
The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab (2001) 1.54
Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes. J Immunol (2000) 1.54
Hereditary factors in sleepwalking and night terrors. Br J Psychiatry (1980) 1.54
IL-12, TNF-alpha, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J Clin Endocrinol Metab (2001) 1.53
Inhibition of Th1 immune response by glucocorticoids: dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes. J Immunol (2000) 1.52
Effects of placebo and flurazepam on sleep patterns in insomniac subjects. Clin Pharmacol Ther (1971) 1.51